Literature DB >> 27443591

Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature.

Niv Segal1, David Greenberg1, Ron Dagan2, Shalom Ben-Shimol3.   

Abstract

BACKGROUND: Invasive pneumococcal disease (IPD) and pneumonia are major causes of morbidity, especially in developing countries. While pneumococcal disease rates differences between various populations are well known, data are scarce regarding disparities in PCV impact on pneumococcal disease rates between populations living in the same country.
OBJECTIVE: The aim of this systematic literature review was to describe disparities in PCV impact between different populations.
METHODS: A systematic literature search was performed using the PubMed database. Studies evaluating pneumococcal disease rates at any age were included. The search was limited to articles written in English and published between 2000 and 2015. Independent extraction of articles was performed by two authors (NS, SB-S). Search terms included: pneumococcus, pneumococcal disease, IPD, pneumonia, PCV, pneumococcal vaccine, population, race, ethnicity, differences, and disparity. We defined resource-poor populations as African-Americans, Aboriginal, Alaska natives and Navajo native-Americans populations compared with the respective resource-rich populations, including White, non-Aboriginal, non-Alaska natives and general US population.
RESULTS: Eighteen articles meeting the selection criteria were identified; 17 regarding IPD and one regarding pneumonia. Nine articles compared IPD rates in African-Americans and Whites in the US, six compared Aboriginal and non-Aboriginal populations; two compared Alaska natives vs. non-native Alaskans in the US and one article compared Navajo native-Americans and general population in the US. Only minor difference where usually noted in the incidence rate ratios (IRRs) comparing pre- and post-PCV rates of IPD and pneumonia between resource rich and resource poor populations. In contrast, absolute rate reductions were higher in resource-poor compared with resource-rich populations.
CONCLUSION: While differences in IPD and pneumonia rates between resource-poor and resource-rich populations were decreased following PCV introduction, disparity is still apparent and is not fully eliminated in any of the studies. Younger (<2years) populations in resource-poor populations seem to benefit the most from PCV introduction.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Differences; Disparity; Ethnicity; Invasive pneumococcal disease (IPD); Pneumococcal conjugate vaccine (PCV); Pneumococcal disease; Pneumococcal vaccine; Pneumonia; Population; Race; Streptococcus pneumoniae

Mesh:

Substances:

Year:  2016        PMID: 27443591     DOI: 10.1016/j.vaccine.2016.07.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

Review 1.  Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.

Authors:  Andrew D Wiese; Marie R Griffin; Carlos G Grijalva
Journal:  Expert Rev Vaccines       Date:  2019-03-20       Impact factor: 5.217

2.  Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments.

Authors:  T J Marrie; G J Tyrrell; Sumit R Majumdar; Dean T Eurich
Journal:  Can Respir J       Date:  2017-03-23       Impact factor: 2.409

Review 3.  Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.

Authors:  Kelly J Mrklas; Shannon MacDonald; Melissa A Shea-Budgell; Nancy Bedingfield; Heather Ganshorn; Sarah Glaze; Lea Bill; Bonnie Healy; Chyloe Healy; Juliet Guichon; Amy Colquhoun; Christopher Bell; Ruth Richardson; Rita Henderson; James Kellner; Cheryl Barnabe; Robert A Bednarczyk; Angeline Letendre; Gregg S Nelson
Journal:  Syst Rev       Date:  2018-03-02

4.  Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.

Authors:  Eileen M Dunne; Catherine Satzke; Felisita T Ratu; Eleanor F G Neal; Laura K Boelsen; Silivia Matanitobua; Casey L Pell; Monica L Nation; Belinda D Ortika; Rita Reyburn; Kylie Jenkins; Cattram Nguyen; Katherine Gould; Jason Hinds; Lisi Tikoduadua; Joseph Kado; Eric Rafai; Mike Kama; E Kim Mulholland; Fiona M Russell
Journal:  Lancet Glob Health       Date:  2018-12       Impact factor: 26.763

5.  Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006-2015.

Authors:  Daniel Dalcin; Lee Sieswerda; Sacha Dubois; Marina Ulanova
Journal:  BMC Infect Dis       Date:  2018-12-04       Impact factor: 3.090

6.  Development and validation of a search filter to identify equity-focused studies: reducing the number needed to screen.

Authors:  Stephanie L Prady; Eleonora P Uphoff; Madeleine Power; Su Golder
Journal:  BMC Med Res Methodol       Date:  2018-10-12       Impact factor: 4.615

7.  Effectiveness of the 10-valent pneumococcal conjugate vaccine on pediatric pneumonia confirmed by ultrasound: a matched case-control study.

Authors:  William Checkley; Shakir Hossen; Eric D McCollum; Farhan Pervaiz; Catherine H Miele; Miguel A Chavez; Lawrence H Moulton; Nicole Simmons; Arunangshu D Roy; Nabidul H Chowdhury; Salahuddin Ahmed; Nazma Begum; Abdul Quaiyum; Mathuram Santosham; Abdullah H Baqui
Journal:  Respir Res       Date:  2022-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.